Literature DB >> 3684225

Use of one-piece valved tube and variable surface area explant for glaucoma drainage surgery.

R A Hitchings1, N H Joseph, M B Sherwood, J Lattimer, M Miller.   

Abstract

The results of glaucoma surgery on 37 eyes of 36 patients after the use of a one-piece valved silicone explant are described. With a follow-up of 6 to 24 months, intraocular pressures (IOPs) averaging 8.0 to 17.3 mmHg were recorded. The maximum number of eyes receiving antiglaucoma medicines at any of the follow-up visits was six. These results were compared with the authors' previous results with the two-piece tube and gutter explant (ACTSEB). It was found that lower IOPs were obtained with fewer complications from overdrainage in the immediate postoperative period. This difference was attributed to the valve reducing but not preventing overdrainage and less chance of "fibrosis" blocking the tube/plate interface.

Entities:  

Mesh:

Year:  1987        PMID: 3684225     DOI: 10.1016/s0161-6420(87)33320-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  A one-piece ocular drainage implant for glaucoma surgery: a preliminary report.

Authors:  M Kivalo; C Raitta; T Mononen
Journal:  Acta Vet Scand       Date:  1992       Impact factor: 1.695

2.  Pars plana vitrectomy with pars plana tube implantation in eyes with intractable glaucoma.

Authors:  S Kaynak; N F Tekin; I Durak; A T Berk; A O Saatci; M F Soylev
Journal:  Br J Ophthalmol       Date:  1998-12       Impact factor: 4.638

3.  Transvitreal endocyclophotocoagulation.

Authors:  J A Haller
Journal:  Trans Am Ophthalmol Soc       Date:  1996

4.  A comparison between tube surgery, ND:YAG laser and diode laser cyclophotocoagulation in the management of refractory glaucoma.

Authors:  Philip A Bloom; Colin I Clement; Anthony King; Baha Noureddin; Kamal Sharma; Roger A Hitchings; Peng T Khaw
Journal:  Biomed Res Int       Date:  2013-10-07       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.